Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 12, 1999

View Archived Issues

Micrologix initiates phase II safety studies of fast-track development candidate

Animal model shows Toleragen reduces production of antiphospholipid antibodies

Full enrollment reached in phase III trial of GMK cancer vaccine

MS-377 improves positive and negative symptoms of schizophrenia, without causing EPS

Cerus awarded NIH grant for allogeneic bone marrow transplant research

RPR sublicenses hormone replacement products to Novartis

Experimental hepatitis B vaccine includes a novel adjuvant; efficacy in nonresponders

Enzo Biochem's HGTV43 achieves high levels of gene delivery to human cells

Titan receives NIH grant for support of Parkinson's disease therapy

Sheffield and Elan establish licensing agreement to develop respiratory products

Venlafaxine as a nonhormonal treatment for hot flashes associated with androgen deprivation

Licensing opportunity from NIH: novel integrin antagonists for treating inflammatory disease

NO-generating prodrugs available for licensing from NIH

EM-800 unexpectedly found to resemble raloxifene more closely than fulvestrant

FDA approves Prozac for treatment of geriatric depression

Gemin X discovers novel Bcl-2 inhibitor as anticancer agent

Several candidates in Fujisawa's pipeline progressing in phase II and III trials

New British Biotech esters inhibit tumor cell proliferation

Potent and selective alpha1-adrenoceptor ligands and their use presented by Lundbeck

Inhibitors of Src PTKs from BMS particularly useful for T-cell-mediated disorders

Selective beta3-adrenoceptor agonists in development at Merck

Decatromicins: novel antibiotics produced by Actinomadura

Initial results point to efficacy and safety of BCH-10652 in HIV-infected patients

Activity of new triazole antifungal BMS-207147 further characterized in vitro

Triangle presents promising data on Coactinon at ICAAC, but reports interaction with nelfinavir

Antiretroviral-naive patients respond similarly to lodenosine and lamivudine in combination regimens

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...